A blueberry-enriched diet improves renal function and reduces oxidative stress in metabolic syndrome animals: Potential mechanism of TLR4-MAPK signaling pathway

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Nair, Anand R ^a   Elks, Carrie M ^a,b   Vila, Jorge ^a   Del Piero, Fabio ^a   Paulsen, Daniel B ^a   Francis, Joseph ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLUEBERRY; CONTROLLED STUDY; DIETARY INTAKE; ENZYME INHIBITION; GENE EXPRESSION; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; KIDNEY CLEARANCE; KIDNEY FUNCTION; MALE; METABOLIC SYNDROME X; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; RENAL SYSTEM PARAMETERS; SIGNAL TRANSDUCTION; ANIMAL; BODY WEIGHT; CHEMISTRY; DIET; DISEASE MODEL; GENETICS; GLOMERULUS; HEMODYNAMICS; KIDNEY; KIDNEY FUNCTION TEST; KNOCKOUT MOUSE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION;

ANIMALIA; VACCINIUM;

ANIMALS; BLUEBERRY PLANT; BODY WEIGHT; DIET; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; GLUCOSE; HEMODYNAMICS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; MALE; METABOLIC SYNDROME X; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; TOLL-LIKE RECEPTOR 4;

EID: 84910626509     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111976     Document Type: Article

References (61)

1. Ervin RB (2009) Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report: 1-7.
2. Khoo MC, Oliveira FM, Cheng L (2013) Understanding the metabolic syndrome: a modeling perspective. IEEE Rev Biomed Eng 6: 143-155.
3. Elks CM, Mariappan N, Haque M., Guggilam A, Majid DS, et al. (2009) Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am J Physiol Renal Physiol 296: F298-305.
4. Elks CM, Francis J, Stull A.J., Cefalu WT, Shukitt-Hale B, et al. (2013) Overview of the Health Properties of Blueberries. In: Hunter MSaD, editor. Bioactives in Fruit: Health Benefits and Functional Foods Oxford, UK: John Wiley & Sons, Ltd. doi:10.1002/9781118635551.ch11.
5. Elks CM, Reed SD, Mariappan N, Shukitt-Hale B, Joseph J.A., et al. (2011) A blueberry-enriched diet attenuates nephropathy in a rat model of hypertension via reduction in oxidative stress. PLoS One 6: e24028.
6. Nair AR, Masson GS, Ebenezer P.J., Del Piero F, Francis J (2014) Role of TLR4 in lipopolysaccharide-induced acute kidney injury: Protection by blueberry. Free Radic Biol Med 71C: 16-25.
7. Neri M, Cerretani D, Fiaschi A.I., Laghi PF, Lazzerini PE, et al. (2007) Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. J Cell Mol Med 11: 156-170.
8. Mariappan N, Soorappan RN, Haque M, Sriramula S., Francis J (2007) TNF-alpha-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. Am J Physiol Heart Circ Physiol 293: H2726-2737.
9. Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844.
10. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
11. Medzhitov R, Preston-Hurlburt P, Kopp E., Stadlen A, Chen C, et al. (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2: 253-258.
12. Muzio M, Natoli G, Saccani S., Levrero M, Mantovani A (1998) The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 187: 2097-2101.
13. Xu XH, Shah PK, Faure E, Equils O., Thomas L, et al. (2001) Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104: 3103-3108.
14. Hardy OT, Kim A, Ciccarelli C., Hayman LL, Wiecha J (2013) Increased Tolllike receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents. Pediatr Obes 8: e19-23.
15. Peroval MY, Boyd AC, Young J.R., Smith al (2013) A critical role for MAPK signalling pathways in the transcriptional regulation of toll like receptors. PLoS One 8: e51243.
16. Thobe BM, Frink M, Hildebrand F., Schwacha MG, Hubbard WJ, et al. (2007) The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage. J Cell Physiol 210: 667-675.
17. Good DW, George T, Watts BA 3rd (2009) Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes. Am J Physiol Renal Physiol 297: F866-874.
18. Ta NN, Li Y, Schuyler C.A., Lopes-Virella MF, Huang Y (2010) DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes. Atherosclerosis 213: 429-435.
19. Tan Y, Ichikawa T, Li J., Si Q, Yang H, et al. (2011) Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 60: 625-633.
20. Pamidimukkala J, Jandhyala BS (2004) Effects of salt rich diet in the obese Zucker rats: studies on renal function during isotonic volume expansion. Clin Exp Hypertens 26: 55-67.
21. Slyvka Y, Inman SR, Malgor R, Jackson E.J., Yee J., et al. (2009) Protective effects of antioxidant-fortified diet on renal function and metabolic profile in obese Zucker rat. Endocrine 35: 89-100.
22. Freeman LR, Zhang L, Nair A., Dasuri K, Francis J, et al. (2013) Obesity increases cerebrocortical reactive oxygen species and impairs brain function. Free Radic Biol Med 56: 226-233.
23. Wilson CB, McLaughlin LD, Nair A, Ebenezer P.J., Dange R., et al. (2013) Inflammation and oxidative stress are elevated in the brain, blood, and adrenal glands during the progression of post-traumatic stress disorder in a predator exposure animal model. PLoS One 8: e76146.
24. Wilson CB, McLaughlin LD, Ebenezer P.J., Nair AR, Francis J (2014) Valproic acid effects in the hippocampus and prefrontal cortex in an animal model of post-traumatic stress disorder. Behav Brain Res.
25. Peng H, Li W, Seth D.M., Nair AR, Francis J, et al. (2013) (Pro)renin receptor mediates both angiotensin II-dependent and -independent oxidative stress in neuronal cells. PLoS One 8: e58339.
26. El-Atat FA, Stas SN, McFarlane S.I., Sowers JR (2004) The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 15: 2816-2827.
27. Wahba IM, Mak RH (2007) Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2: 550-562.
28. Cha JJ, Hyun YY, Lee M.H., Kim JE, Nam DH, et al. (2013) Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology 154: 2144-2155.
29. Thomas G, Sehgal AR, Kashyap S.R., Srinivas TR, Kirwan JP, et al. (2011) Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364-2373.
30. Johns BR, Pao AC, Kim SH (2012) Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrol Dial Transplant 27: 1410-1415.
31. Polichnowski AJ, Jin C, Yang C., Cowley AW, Jr. (2010) Role of renal perfusion pressure versus angiotensin II on renal oxidative stress in angiotensin II-induced hypertensive rats. Hypertension 55: 1425-1430.
32. Hisada Y, Sugaya T, Yamanouchi M., Uchida H, Fujimura H, et al. (1999) Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103: 627-635.
33. Youn JY, Siu KL, Lob H, Itani H., Harrison DG, et al. (2014) Role of Vascular Oxidative Stress in Obesity and Metabolic Syndrome. Diabetes.
34. Khoo NK, Cantu-Medellin N, Devlin J.E., St Croix CM, Watkins SC, et al. (2012) Obesity-induced tissue free radical generation: an in vivo immuno-spin trapping study. Free Radic Biol Med 52: 2312-2319.
35. Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25.
36. Aksu U, Demirci C, Ince C (2011) The pathogenesis of acute kidney injury and the toxic triangle of oxygen, reactive oxygen species and nitric oxide. Contrib Nephrol 174: 119-128.
37. Fukuyama N, Takebayashi Y, Hida M., Ishida H, Ichimori K, et al. (1997) Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic Biol Med 22: 771-774.
38. Wang C, Blough ER, Arvapalli R, Dai X., Paturi S, et al. (2013) Metabolic syndrome-induced tubulointerstitial injury: role of oxidative stress and preventive effects of acetaminophen. Free Radic Biol Med 65: 1417-1426.
39. Tabet F, Savoia C, Schiffrin E.L., Touyz RM (2004) Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 44: 200-208.
40. Moss NG, Vogel PA, Kopple T.E., Arendshorst WJ (2013) Thromboxane-induced renal vasoconstriction is mediated by the ADP-ribosyl cyclase CD38 and superoxide anion. Am J Physiol Renal Physiol 305: F830-838.
41. Kambham N, Markowitz GS, Valeri A.M., Lin J., D'Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59: 1498-1509.
42. Chen J, Muntner P, Hamm L.L., Jones DW, Batuman V, et al. (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174.
43. Adelman RD, Restaino IG, Alon U.S., Blowey DL (2001) Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 138: 481-485.
44. Hall AM, Bass P, Unwin RJ (2014) Drug-induced renal Fanconi syndrome. QJM 107: 261-269.
45. Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. Faseb j 18: 816-827.
46. Lepenies J, Eardley KS, Kienitz T, Hewison M., Ihl T, et al. (2011) Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-beta(1) in patients with chronic kidney disease. Nephron Clin Pract 119: c97-c104.
47. Ha H, Yu MR, Kim KH (1999) Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic Biol Med 26: 944-950.
48. Eguchi K, Manabe I (2014) Toll-Like Receptor, Lipotoxicity and Chronic inflammation: The Pathological Link Between Obesity and Cardiometabolic Disease. J Atheroscler Thromb.
49. Kim D, Lee JE, Jung Y.J., Lee AS, Lee S, et al. (2013) Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice. Int J Mol Med 32: 1293-1302.
50. Koc M, Toprak A, Arikan H., Odabasi Z, Elbir Y, et al. (2011) Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation. Nephrol Dial Transplant 26: 955-963.
51. Xi L, Xiao C, Bandsma R.H., Naples M., Adeli K, et al. (2011) C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases. Hepatology 53: 127-135.
52. Long HD, Lin YE, Liu M.J., Liang LY, Zeng ZH (2013) Spironolactone prevents dietary-induced metabolic syndrome by inhibiting PI3-K/Akt and p38MAPK signaling pathways. J Endocrinol Invest 36: 923-930.
53. Cui XL, Ding Y, Alexander L.D., Bao C., Al-Khalili OK, et al. (2006) Oxidative signaling in renal epithelium: Critical role of cytosolic phospholipase A2 and p38(SAPK). Free Radic Biol Med 41: 213-221.
54. Jin Jung K, Hyun Kim D, Kyeong Lee E, Woo Song C, Pal Yu B, et al. (2013) Oxidative stress induces inactivation of protein phosphatase 2A, promoting proinflammatory NF-kappaB in aged rat kidney. Free Radic Biol Med 61C: 206-217.
55. Mogensen TH (2009) Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses. Clinical Microbiology Reviews 22: 240-273.
56. Queisser N, Schupp N (2012) Aldosterone, oxidative stress, and NF-kappaB activation in hypertension-related cardiovascular and renal diseases. Free Radic Biol Med 53: 314-327.
57. Pedruzzi LM, Stockler-Pinto MB, Leite M Jr, Mafra D (2012) Nrf2-keap1? system versus NF-kappaB: the good and the evil in chronic kidney disease? Biochimie 94: 2461-2466.
58. Yang SM, Chan YL, Hua K.F., Chang JM, Chen HL, et al. (2014) Osthole improves an accelerated focal segmental glomerulosclerosis model in early stage by activating Nrf2 antioxidant pathway and subsequent inhibition of NF-kappaB-mediated COX-2 expression and apoptosis. Free Radic Biol Med.
59. Rodrigo R, Rivera G (2002) Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Radic Biol Med 33: 409-422.
60. Bellezza I, Mierla al, Minelli A (2010) Nrf2 and NF-kappaB and Their Concerted Modulation in Cancer Pathogenesis and Progression. Cancers (Basel) 2: 483-497.
61. Itoh K, Wakabayashi N, Katoh Y., Ishii T, O'Connor T, et al. (2003) Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8: 379-391.